Boston Scientific Unit Can't Duck FCA Claims, DQ Blank Rome

Law360, New York (May 31, 2013, 6:47 PM EDT) -- A Boston Scientific Corp. unit failed Friday to shake whistleblower claims in New Jersey federal court alleging it illegally paid doctors to promote off-label uses of its spinal cord device and of billing Medicare and Medicaid for such uses, and couldn't stop Blank Rome LLP from representing former employees making the allegations.

U.S. District Judge Susan D. Wigenton ruled Friday that the relators had made sufficiently specific claims against Boston Scientific Neuromodulation Corp., with enough details for their claims to proceed. The relators bringing the False...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.